With a mean age of onset of 59 years in affected GRN pathogenic variant carriers in our total cohort, it cannot be excluded that these presymptomatic GRN pathogenic variant carriers will still develop FTD at a later age; however, one of these presymptomatic GRN pathogenic variant carriers remained without symptoms at 68 years of age. This evidence concerns the gene GRN and frontotemporal dementia.